These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 12700181)

  • 41. Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica.
    Cutolo M; Foppiani L; Minuto F
    J Endocrinol Invest; 2002; 25(10 Suppl):19-23. PubMed ID: 12508908
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypothalamic-Pituitary-Adrenal Hypofunction in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) as a Consequence of Activated Immune-Inflammatory and Oxidative and Nitrosative Pathways.
    Morris G; Anderson G; Maes M
    Mol Neurobiol; 2017 Nov; 54(9):6806-6819. PubMed ID: 27766535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary free cortisol excretion in chronic fatigue syndrome, major depression and in healthy volunteers.
    Scott LV; Dinan TG
    J Affect Disord; 1998 Jan; 47(1-3):49-54. PubMed ID: 9476743
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuroendocrine aspects of chronic fatigue syndrome.
    Papanicolaou DA; Amsterdam JD; Levine S; McCann SM; Moore RC; Newbrand CH; Allen G; Nisenbaum R; Pfaff DW; Tsokos GC; Vgontzas AN; Kales A
    Neuroimmunomodulation; 2004; 11(2):65-74. PubMed ID: 14758052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Altered psychobiological responsiveness in women with irritable bowel syndrome.
    Suárez-Hitz KA; Otto B; Bidlingmaier M; Schwizer W; Fried M; Ehlert U
    Psychosom Med; 2012; 74(2):221-31. PubMed ID: 22286854
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Research progress in the treatment of chronic fatigue syndrome through interventions targeting the hypothalamus-pituitary-adrenal axis.
    Zhang YD; Wang LN
    Front Endocrinol (Lausanne); 2024; 15():1373748. PubMed ID: 38660512
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new model for the HPA axis explains dysregulation of stress hormones on the timescale of weeks.
    Karin O; Raz M; Tendler A; Bar A; Korem Kohanim Y; Milo T; Alon U
    Mol Syst Biol; 2020 Jul; 16(7):e9510. PubMed ID: 32672906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HPA axis reactivity and lymphocyte glucocorticoid sensitivity in fibromyalgia syndrome and chronic pelvic pain.
    Wingenfeld K; Heim C; Schmidt I; Wagner D; Meinlschmidt G; Hellhammer DH
    Psychosom Med; 2008 Jan; 70(1):65-72. PubMed ID: 18158367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome.
    Kavelaars A; Kuis W; Knook L; Sinnema G; Heijnen CJ
    J Clin Endocrinol Metab; 2000 Feb; 85(2):692-6. PubMed ID: 10690878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dehydroepiandrosterone sulfate deficiency in chronic fatigue syndrome.
    Kuratsune H; Yamaguti K; Sawada M; Kodate S; Machii T; Kanakura Y; Kitani T
    Int J Mol Med; 1998 Jan; 1(1):143-6. PubMed ID: 9852212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function.
    Karanth S; Linthorst AC; Stalla GK; Barden N; Holsboer F; Reul JM
    Endocrinology; 1997 Aug; 138(8):3476-85. PubMed ID: 9231802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Chronic fatigue syndrome in school children].
    Kawa K
    Nihon Rinsho; 1992 Nov; 50(11):2606-11. PubMed ID: 1287237
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India.
    Chittiprol S; Kumar AM; Satishchandra P; Taranath Shetty K; Bhimasena Rao RS; Subbakrishna DK; Philip M; Satish KS; Ravi Kumar H; Kumar M
    Psychoneuroendocrinology; 2008 Jan; 33(1):30-40. PubMed ID: 17993249
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New insights into the role of perinatal HPA-axis dysregulation in postpartum depression.
    Glynn LM; Davis EP; Sandman CA
    Neuropeptides; 2013 Dec; 47(6):363-70. PubMed ID: 24210135
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Linking disease symptoms and subtypes with personalized systems-based phenotypes: a proof of concept study.
    Aschbacher K; Adam EK; Crofford LJ; Kemeny ME; Demitrack MA; Ben-Zvi A
    Brain Behav Immun; 2012 Oct; 26(7):1047-56. PubMed ID: 22687333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduction of Glucocorticoid Receptor Function in Chronic Fatigue Syndrome.
    Lynn M; Maclachlan L; Finkelmeyer A; Clark J; Locke J; Todryk S; Ng WF; Newton JL; Watson S
    Mediators Inflamm; 2018; 2018():3972104. PubMed ID: 29983634
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhanced feedback sensitivity to prednisolone in chronic fatigue syndrome.
    Jerjes WK; Taylor NF; Wood PJ; Cleare AJ
    Psychoneuroendocrinology; 2007 Feb; 32(2):192-8. PubMed ID: 17276605
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of IL-6, hypothalamus-pituitary-adrenal axis function, and depression in patients with cancer.
    Jehn CF; Kühnhardt D; Bartholomae A; Pfeiffer S; Schmid P; Possinger K; Flath BC; Lüftner D
    Integr Cancer Ther; 2010 Sep; 9(3):270-5. PubMed ID: 20702499
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dehydroepiandrosterone sulfate in the assessment of the hypothalamic-pituitary-adrenal axis.
    Fischli S; Jenni S; Allemann S; Zwahlen M; Diem P; Christ ER; Stettler C
    J Clin Endocrinol Metab; 2008 Feb; 93(2):539-42. PubMed ID: 17986637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuroendocrine mechanisms in fibromyalgia-chronic fatigue.
    Buskila D; Press J
    Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):747-58. PubMed ID: 11812019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.